Knowledge of placebo and nocebo effects is essential to identify their influence on the results in clinical practice and clinical trials, and thereby properly interpret their results. It is known that the gold standard of clinical trials research is the double-blind, placebo-controlled, randomized clinical study. The objective of this review is to distinguish specific from non-specific effects, so that the presence of positive effects in the group that received placebo (placebo effect) and the presence of adverse effects in the group receiving placebo (nocebo effect) lead to confounding in interpreting the results. Placebo and nocebo effects have been considered in neurological diseases such as depression, pain, headache, multiple sclerosis, epilepsy. As placebo and nocebo effects are also present in clinical practice, the purpose of this review is to draw attention to their influence on neurological practice, calling attention to the development of measures that can minimize them.Keywords: placebo, nocebo, neuropathic pain, headache, multiple sclerosis, epilepsy, clinical trials.RESUMO O conhecimento dos efeitos placebo e nocebo Ă© essencial para identificar a sua influĂȘncia sobre os resultados na prĂĄtica clĂnica e ensaios clĂnicos, e, assim, interpretar corretamente seus resultados. Sabe-se que o padrĂŁo-ouro dos estudos clĂnicos de pesquisa Ă© o ensaio clĂnico randomizado, placebo-controlado, duplo-cego. O objetivo da revisĂŁo Ă© distinguir os efeitos especĂficos e nĂŁo especĂficos, de modo que a presença de efeitos positivos no grupo que recebeu placebo (efeito placebo) e a presença de efeitos adversos no grupo que recebeu placebo (efeito nocebo) levam Ă confusĂŁo na interpretação dos resultados. Placebo e nocebo sĂŁo descritos em doenças neurolĂłgicas como a depressĂŁo, dor, cefaleia, esclerose mĂșltipla, epilepsia. Como os efeitos placebo e nocebo tambĂ©m se projetam na prĂĄtica clĂnica, o objetivo desta revisĂŁo Ă© o de destacar sua influĂȘncia na prĂĄtica neurolĂłgica, chamando a atenção para o desenvolvimento de medidas que possam minimizĂĄ-los.Palavras-chave: placebo, nocebo, dor neuropĂĄtica, cefaleia, esclerose mĂșltipla, epilepsia, ensaios clĂnicos.The knowledge of the neurobiology and psychology of the placebo and nocebo effects is of great importance, as it can aggregate into basic and clinical research, and in neurological practice 1 . Further, in order to understand better what these effects mean and how do they act, it is possible to evaluate their influence in clinical trials and try to minimize them, by changing the design of such trials in which treatment is tested against a placebo 2 . Additionally, a better understanding of these effects may reflect in changes in health care systems, forcing us to think always on the significance of the placebo and nocebo effects in clinical practice, and to standardize actions to minimize their influence. The progress in this field becomes evident by the growing number of publications involving placebo and nocebo effects, including their prevalence, physiology, impact...